Electrochemical test paper stabilizer and use thereof

By using stabilizers of colloids, casein and other components in electrochemical test strips, the problem of low thermal stability of enzyme sensor electrochemical test strips is solved, and high stability and detection accuracy are achieved for storage at room temperature, reducing costs .

WO2024239234A1PCT designated stage expired Publication Date: 2024-11-28SICHUAN MACCURA BIOTECH CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2023/095781
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-23
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Existing enzyme sensor electrochemical test strips have problems such as low thermal stability, high storage cost, reduced detection accuracy and sensitivity, especially when it contains potassium ferrocyanide and biological enzymes.

Method used

Using stabilizers composed of colloids, casein, buffer solutions with pH values ​​of 2 to 5, chitin oligosaccharides, bovine serum albumin and preservatives, electrochemical test strips are prepared by dispersing these components in buffer solution to ensure biological Enzymes and potassium ferricyanide remain stable at room temperature.

Benefits of technology

The stability of electrochemical test strips stored at room temperature and high detection accuracy and sensitivity after long-term storage are achieved, reducing the preparation and storage cost.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PCTCN2023095781-FTAPPB-I100001
    Figure PCTCN2023095781-FTAPPB-I100001
  • Figure PCTCN2023095781-FTAPPB-I100002
    Figure PCTCN2023095781-FTAPPB-I100002
  • Figure PCTCN2023095781-FTAPPB-I100003
    Figure PCTCN2023095781-FTAPPB-I100003
Patent Text Reader

Abstract

An electrochemical test paper stabilizer and the use thereof. The components of the stabilizer comprise: a colloid, a casein, a buffer solution having a pH value of 2-5, an optional chitosan oligosaccharide, an optional bovine serum albumin, and an optional preservative. In the stabilizer, the mass percentage of the colloid is 0.8-5 wt%, the mass percentage of the casein is 0.2-10 wt%, the mass percentage of the chitosan oligosaccharide is 0-5 wt%, the mass percentage of the bovine serum albumin is 0-2 wt%, and the mass percentage of the preservative is 0-0.1 wt%. The electrochemical test paper prepared by using the stabilizer can be stored at normal temperature, and can still maintain relatively high levels of detection accuracy and sensitivity after long-time storage.
Need to check novelty before this filing date? Find Prior Art

Description

Electrochemical test paper stabilizer and application thereof Technical Field

[0001] The invention belongs to the technical field of analyte detection, and in particular relates to an electrochemical test paper stabilizer and application thereof. Background Art

[0002] Monitoring certain bodily functions, such as the concentration of one or more analytes, plays a vital role in the prevention and treatment of various diseases. Biological fluids (blood, tears, saliva, sweat, urine, etc.) typically contain electrolytes, metabolites, and hormones. Chemical sensors can provide important physiological information by detecting and analyzing these biomarkers, thereby enabling early diagnosis and prevention of diseases. Biosensors are a special type of chemical sensor. They use bioactive units (such as enzymes, antibodies, nucleic acids, cells, etc.) as biosensitive elements and are highly selective detectors for their targets. Enzyme biosensors are the most widely studied. Enzyme sensors are a type of biosensor that selectively measure a component by converting the amount of a substance produced or consumed by a biochemical reaction into an electrical signal through an electrochemical device. The main components of enzyme sensors include electrochemical test strips composed of a biological enzyme layer combined with various electrochemical electrodes or by directly immobilizing the enzyme membrane on a substrate electrode. Common enzyme sensors include glucose sensors, creatine and creatinine electrochemical sensors, cholesterol sensors, lactate electrochemical sensors, uric acid electrochemical sensors, and purine electrochemical sensors.

[0003] Numerous enzyme sensors have been disclosed in the prior art. However, the inventors of the present invention have discovered that the electrochemical test paper, a key component of existing enzyme sensors, suffers from low thermal stability and requires low-temperature storage, making storage difficult and costly. Furthermore, prolonged storage significantly reduces detection accuracy and sensitivity. In particular, when the electrochemical test paper contains both potassium ferrocyanide and a biological enzyme, maintaining both simultaneously is difficult. Consequently, the preparation of the electrochemical test paper requires the use of large amounts of potassium ferrocyanide or the biological enzyme to mitigate inactivation, or the use of low-temperature storage, which increases the production and storage costs of the electrochemical test paper.

[0004] Summary of the Invention

[0005] In response to the deficiencies of the prior art, the present invention aims to provide a stabilizer for electrochemical test paper and its application. The stabilizer can ensure that both the biological enzyme and potassium ferrocyanide in the electrochemical test paper have good stability. The electrochemical test paper prepared using the stabilizer of the present invention can be stored at room temperature and can still maintain high detection accuracy and sensitivity after long-term storage.

[0006] The purpose of the present invention is achieved through the following technical solutions:

[0007] In a first aspect, the present invention provides a stabilizer for an electrochemical test paper, wherein the components of the stabilizer include: a colloid, casein, a buffer solution with a pH value of 2 to 5, and optionally chitosan oligosaccharides, optionally bovine serum albumin (BSA), and an optional preservative; the mass percentage of the colloid in the stabilizer is 0.8 to 5wt%, the mass percentage of the casein is 0.2 to 10wt%, the mass percentage of the chitosan oligosaccharides is 0 to 5wt%, the mass percentage of the bovine serum albumin is 0 to 2wt%, and the mass percentage of the preservative is 0 to 0.1wt%.

[0008] In some embodiments of the present invention, the components of the stabilizer include: colloid, casein, and a buffer solution with a pH value of 2 to 5; the mass percentage of the colloid in the stabilizer is 2 to 5 wt%, and the mass percentage of the casein is 5 to 10 wt%, or the mass percentage of the colloid in the stabilizer is 3 to 5 wt%, and the mass percentage of the casein is 4 to 10 wt%, or the mass percentage of the colloid in the stabilizer is 5 wt%, and the mass percentage of the casein is 0.2 to 10 wt%.

[0009] In some embodiments of the present invention, the components of the stabilizer include: colloid, casein, and a buffer solution with a pH value of 2 to 5; the mass percentage of the colloid in the stabilizer is 3 to 5 wt%, and the mass percentage of the casein is 5 to 10 wt%, or the mass percentage of the colloid in the stabilizer is 5 wt%, and the mass percentage of the casein is 0.5 to 10 wt%.

[0010] In some embodiments of the present invention, the components of the stabilizer include: colloid, casein, and a buffer solution with a pH value of 2 to 5; the mass percentage of the colloid in the stabilizer is 4 to 5 wt%, and the mass percentage of the casein is 10 wt%, or the mass percentage of the colloid in the stabilizer is 5 wt%, and the mass percentage of the casein is 1 to 10 wt%.

[0011] In some embodiments of the present invention, the components of the stabilizer include: colloid, casein, chitosan oligosaccharide, and a buffer solution with a pH value of 2 to 5; the mass percentage of the colloid in the stabilizer is 2 to 5wt%, the mass percentage of the casein is 3 to 10wt%, and the mass percentage of the chitosan oligosaccharide is 2 to 5wt%.

[0012] In some embodiments of the present invention, the components of the stabilizer include: colloid, casein, chitosan oligosaccharide, and a buffer solution with a pH value of 2 to 5; the mass percentage of the colloid in the stabilizer is 4 to 5wt%, the mass percentage of the casein is 5 to 10wt%, and the mass percentage of the chitosan oligosaccharide is 4 to 5wt%.

[0013] In some embodiments of the present invention, the components of the stabilizer include: colloid, casein, chitosan oligosaccharide, preservative, and a buffer solution with a pH value of 2 to 5; the mass percentage of the colloid in the stabilizer is 2 to 5wt%, the mass percentage of casein is 3 to 10wt%, the mass percentage of chitosan oligosaccharide is 2 to 5wt%, and the mass percentage of the preservative is 0.1wt%.

[0014] In some embodiments of the present invention, the components of the stabilizer include: colloid, casein, chitosan oligosaccharide, BSA, a preservative, and a buffer solution with a pH value of 2 to 5; the mass percentage of the colloid in the stabilizer is 0.8 to 5wt%, the mass percentage of casein is 1 to 10wt%, the mass percentage of chitosan oligosaccharide is 0.8 to 5wt%, the mass percentage of BSA is 0.5 to 2wt%, and the mass percentage of the preservative is 0 to 0.1wt%.

[0015] In some embodiments of the present invention, the mass percentage of the colloid in the stabilizer is selected from 0.8wt%, 1wt%, 2wt%, 3wt%, 4wt%, 5wt% or any range consisting of them, preferably 2-5wt%, more preferably 3-5wt%, further preferably 4-5wt%, and most preferably 5wt%.

[0016] In some embodiments of the present invention, the colloid is selected from any one or more of gelatin, pectin, carrageenan, and agar; preferably, the colloid is gelatin.

[0017] In some embodiments of the present invention, the mass percentage of casein in the stabilizer is selected from 0.2wt%, 1wt%, 2wt%, 3wt%, 4wt%, 5wt%, 6wt%, 7wt%, 8wt%, 9wt%, 10wt% or any range consisting of them, preferably 4-10wt%, more preferably 5-10wt%.

[0018] In some embodiments of the present invention, the mass percentage of chitosan oligosaccharide in the stabilizer is selected from 0.8wt%, 1wt%, 2wt%, 3wt%, 4wt%, 5wt% or any range consisting of them, preferably 2-5wt%, more preferably 3-5wt%, and further preferably 4-5wt%.

[0019] In some embodiments of the present invention, the chitosan oligosaccharide has a degree of polymerization of 2 to 10; more preferably, the chitosan oligosaccharide has a degree of polymerization of 2 to 6; most preferably, the chitosan oligosaccharide is selected from chitobiose and / or chitotriose.

[0020] In some embodiments of the present invention, the mass percentage of BSA in the stabilizer is selected from 0.5wt%, 0.8wt%, 1wt%, 1.2wt%, 1.5wt%, 1.8wt%, 2wt% or any range consisting of these, preferably 1-2wt%, more preferably 1.2-1.8wt%.

[0021] In some embodiments of the present invention, the pH value of the buffer solution is selected from 2, 2.5, 3, 3.5, 4, 4.5, 5 or any range consisting thereof, preferably 2.5 to 3.5.

[0022] In some embodiments of the present invention, the buffer solution is selected from any one or more of TRIS-HCL buffer solution, citric acid-disodium hydrogen phosphate, ammonia-ammonium chloride buffer, acetic acid-sodium acetate buffer, phosphate buffer, and citric acid; preferably, the buffer solution is selected from TRIS-HCL buffer solution; more preferably, the mass percentage of TRIS-HCL in the TRIS-HCL buffer solution is 0-0.2 wt%, preferably 0.1 wt%.

[0023] In some embodiments of the present invention, the preservative is selected from astaxanthin; preferably, the mass percentage of astaxanthin in the stabilizer is 0 to 0.1 wt%, preferably 0.1 wt%.

[0024] In some embodiments of the present invention, the stabilizer component further includes polyethylene glycol (PEG); preferably, the molecular weight of PEG is 4000-6000.

[0025] In some embodiments of the present invention, the mass percentage of PEG in the stabilizer is 0-0.2 wt%, preferably 0.1 wt%.

[0026] In some embodiments of the present invention, the stabilizer component further includes a surfactant; preferably, the surfactant is a nonionic surfactant; more preferably, the surfactant is selected from Tween-20 and Tween-80.

[0027] In some embodiments of the present invention, the mass percentage of the surfactant in the stabilizer is 0-0.2 wt %, preferably 0.1 wt %.

[0028] In a second aspect, the present invention provides a method for preparing the stabilizer described in the first aspect, the method comprising dispersing the other components of the stabilizer in a buffer solution having a pH of 2 to 5. Specifically, the other components of the stabilizer are dispersed in a buffer solution having a pH of 2 to 5 according to specific mass percentages to prepare a reagent containing the components in the specified mass percentages.

[0029] In some embodiments of the present invention, the preparation method of the stabilizer includes dispersing the colloid, casein, chitosan oligosaccharide, BSA, and preservative in a buffer solution with a pH value of 2 to 5, and preparing a reagent containing 0.8 to 5 wt% colloid, 0.2 to 10 wt% casein, 0 to 5 wt% chitosan oligosaccharide, 0 to 2 wt% BSA, and 0 to 0.1 wt% preservative.

[0030] In some embodiments of the present invention, the method for preparing the stabilizer includes dispersing the colloid and casein in a buffer solution with a pH value of 2 to 5 to prepare a reagent containing 2 to 5 wt% colloid and 5 to 10 wt% casein.

[0031] In some embodiments of the present invention, the method for preparing the stabilizer includes dispersing the colloid and casein in a buffer solution with a pH value of 2 to 5 to prepare a reagent containing 3 to 5 wt% colloid and 4 to 10 wt% casein.

[0032] In some embodiments of the present invention, the method for preparing the stabilizer includes dispersing the colloid and casein in a buffer solution with a pH value of 2 to 5 to prepare a reagent containing 5 wt% colloid and 0.2 to 10 wt% casein.

[0033] In some embodiments of the present invention, the preparation method of the stabilizer includes dispersing colloid, casein, and chitosan oligosaccharide in a buffer solution with a pH value of 2 to 5 to prepare a reagent containing 2 to 5 wt% colloid, 3 to 10 wt% casein, and 2 to 5 wt% chitosan oligosaccharide.

[0034] In some embodiments of the present invention, the preparation method of the stabilizer includes dispersing the colloid, casein, chitosan oligosaccharide, and preservative in a buffer solution with a pH value of 2 to 5, and preparing a reagent containing 2 to 5 wt% colloid, 3 to 10 wt% casein, 2 to 5 wt% chitosan oligosaccharide, and 0.1 wt% preservative.

[0035] In some embodiments of the present invention, the preparation method of the stabilizer includes dispersing the colloid, casein, chitosan oligosaccharide, and BSA in a buffer solution with a pH value of 2 to 5, and preparing a reagent containing 0.8 to 5 wt% colloid, 1 to 10 wt% casein, 0.8 to 5 wt% chitosan oligosaccharide, and 0.5 to 2 wt% BSA.

[0036] In some embodiments of the present invention, the preparation method of the stabilizer includes dispersing the colloid, casein, chitosan oligosaccharide, BSA, and a preservative in a buffer solution with a pH value of 2 to 5, and preparing a reagent containing 0.8 to 5 wt% colloid, 1 to 10 wt% casein, 0.8 to 5 wt% chitosan oligosaccharide, 0.5 to 2 wt% BSA, and 0 to 1 wt% preservative.

[0037] In some embodiments of the present invention, the preparation method of the stabilizer includes dispersing colloid, casein, chitosan oligosaccharide, BSA, preservative, and PEG in a buffer solution with a pH value of 2 to 5, and preparing a reagent containing 0.8 to 5 wt% colloid, 1 to 10 wt% casein, 0.8 to 5 wt% chitosan oligosaccharide, 0.5 to 2 wt% BSA, 0 to 1 wt% preservative, and 0 to 0.2 wt% PEG.

[0038] In some embodiments of the present invention, the preparation method of the stabilizer includes dispersing colloid, casein, chitosan oligosaccharide, BSA, preservative, PEG, and surfactant in a buffer solution with a pH value of 2 to 5, and preparing a reagent containing 0.8 to 5 wt% colloid, 1 to 10 wt% casein, 0.8 to 5 wt% chitosan oligosaccharide, 0.5 to 2 wt% BSA, 0 to 1 wt% preservative, 0 to 0.2 wt% PEG, and 0 to 0.2 wt% surfactant.

[0039] In a third aspect, the present invention provides a use of the stabilizer described in the first aspect or the stabilizer prepared by the preparation method described in the second aspect in preparing electrochemical test paper.

[0040] In some embodiments of the present invention, the electrochemical test paper is an electrochemical test paper comprising a biological enzyme and potassium ferrocyanide. Preferably, the biological enzyme is selected from at least one of lactate oxidase, urate oxidase, cholesterol oxidase, phosphate oxidase, bilirubin oxidase, phosphate oxidase, galactose oxidase, pyruvate oxidase, D-amino acid oxidase, L-amino acid oxidase, choline oxidase, xanthine oxidase, sarcosine oxidase, fructose dehydrogenase, and amino acid dehydrogenase.

[0041] In a fourth aspect, the present invention provides an electrochemical test paper, comprising a biological enzyme layer, wherein the biological enzyme layer includes a biological enzyme, potassium ferrocyanide, and the stabilizer described in the first aspect or the stabilizer prepared in the second aspect.

[0042] In some embodiments of the present invention, the biological enzyme is selected from at least one of lactate oxidase, urate oxidase, cholesterol oxidase, phosphate oxidase, bilirubin oxidase, phosphate oxidase, galactose oxidase, pyruvate oxidase, D-amino acid oxidase, L-amino acid oxidase, choline oxidase, xanthine oxidase, sarcosine oxidase, fructose dehydrogenase, and amino acid dehydrogenase.

[0043] In some embodiments of the present invention, the biological enzyme layer is formed by mixing biological enzymes, potassium ferrocyanide and the stabilizer described in the first aspect or the stabilizer prepared in the second aspect into a mixed solution, and then drying; preferably, the pH value of the mixed solution is 2 to 5, the content of biological enzymes in the mixed solution is 0.05 to 5wt%, and the content of potassium ferrocyanide is 0.05 to 7.5wt%; more preferably, the content of biological enzymes in the mixed solution is 0.1 to 3wt%, and the content of potassium ferrocyanide is 0.1 to 5wt%.

[0044] In a fifth aspect, the present invention provides a method for preparing the electrochemical test paper according to the fourth aspect, the preparation method comprising:

[0045] (1) Preparation of electrodes;

[0046] (2) mixing the biological enzyme, potassium ferrocyanide, and the stabilizer described in the first aspect or the stabilizer prepared in the second aspect to prepare a mixed solution having a pH value of 2 to 5 and containing 0.05 to 5 wt% of the biological enzyme and 0.05 to 7.5 wt% of potassium ferrocyanide;

[0047] (3) The mixed solution obtained in step (2) is dispensed onto the conductive carbon ink coating of the electrode and dried.

[0048] In some embodiments of the present invention, the electrode prepared in step (1) consists of a substrate and a reference electrode, a counter electrode and a working electrode arranged in parallel on the substrate.

[0049] In some embodiments of the present invention, the substrate is made of a polymer insulating material, preferably polyamide.

[0050] In some embodiments of the present invention, the reference electrode is a portion of an electrode printed with a silver ink coating.

[0051] In some embodiments of the present invention, the counter electrode is a partial electrode printed with an insulating ink coating.

[0052] In some embodiments of the present invention, the working electrode is a partial electrode printed with a conductive carbon ink coating.

[0053] In a sixth aspect, the present invention provides an enzyme sensor comprising the electrochemical test paper described in the fourth aspect or the electrochemical test paper prepared by the preparation method described in the fifth aspect.

[0054] The beneficial effects of the present invention are as follows:

[0055] The present invention provides a stabilizer for electrochemical test paper, and the stabilizer component is simple. The inventor unexpectedly found that when a stabilizer containing colloid and casein components is used, the stability of biological enzymes and potassium ferricyanide can be significantly improved. In addition, when chitosan oligosaccharides are contained in the stabilizer, the stability of colloid and casein to biological enzymes and potassium ferricyanide can be further improved, which may be related to the electrostatic effect of chitosan oligosaccharides. When BSA is also contained in the stabilizer, BSA easily combines with chitosan oligosaccharides with low polymerization degree (such as chitobiose and chitotriose), further enhancing the stability of the stabilizer component for biological enzymes. Preservatives can inhibit the growth of bacteria and reduce the adverse effects of bacteria on the activity of biological enzymes. Among them, astaxanthin has an excellent effect of promoting the stability of biological enzymes, which may be due to the weak hydrogen bonds and hydrophobic effects between astaxanthin and colloids, which can promote the combination of colloid, casein and biological enzymes. The addition of surfactants and polyvinyl alcohol can effectively promote the release of biological enzymes on the surface of carbon electrodes and the stability of biological enzymes.

[0056] When the stabilizer component of the present invention includes colloid, casein, and a buffer solution with a pH value of 2 to 5, higher stability can be obtained by appropriately increasing the mass percentage of the colloid and / or casein in the stabilizer; in addition, adding chitosan oligosaccharide, bovine serum albumin, preservatives, polyethylene glycol or surfactants to the stabilizer can also improve the stability of the electrochemical test paper, especially when the mass percentage of the colloid and casein in the stabilizer is relatively low. The stabilizer of the present invention can make the biological enzyme and potassium ferrocyanide in the electrochemical test paper have good stability at room temperature. The electrochemical test paper prepared by using the stabilizer of the present invention can be stored at room temperature and can still maintain high detection accuracy and sensitivity after long-term storage; it has good development prospects in replacing existing electrochemical test paper and replacing existing electrochemical test paper to prepare enzyme sensors. DETAILED DESCRIPTION

[0057] The following examples further illustrate the technology of the present invention. These examples are for illustration and example only and are not intended to limit the scope of the present invention in any form.

[0058] Example 1

[0059] A stabilizer for electrochemical test paper, comprising components of gelatin, casein, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl). A preparation method of the stabilizer comprises dispersing gelatin and casein in a TRIS-HCl buffer solution with a pH value of 2.5 to prepare a stabilizer #1 containing 5 wt% gelatin and 10 wt% casein.

[0060] Example 2

[0061] A stabilizer for electrochemical test paper, comprising components of gelatin, casein, chitobiose, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl). A preparation method of the stabilizer comprises dispersing the gelatin, casein, and chitobiose in a TRIS-HCl buffer solution with a pH value of 2.5 to prepare a stabilizer #2 containing 5 wt% gelatin, 10 wt% casein, and 5 wt% chitobiose.

[0062] Example 3

[0063] A stabilizer for electrochemical test paper, comprising components of gelatin, casein, chitobiose, BSA, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl). A preparation method of the stabilizer comprises dispersing the gelatin, casein, chitobiose, and BSA in a TRIS-HCl buffer solution with a pH value of 2.5 to prepare a stabilizer 3# containing 5 wt% gelatin, 10 wt% casein, 5 wt% chitobiose, and 0.5 wt% BSA.

[0064] Example 4

[0065] A stabilizer for electrochemical test paper, comprising components of gelatin, casein, chitobiose, astaxanthin, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl). A preparation method of the stabilizer comprises dispersing the gelatin, casein, chitobiose, and astaxanthin in a TRIS-HCl buffer solution with a pH value of 2.5 to prepare a stabilizer 4# containing 5 wt% gelatin, 10 wt% casein, 5 wt% chitobiose, and 0.1 wt% astaxanthin.

[0066] Example 5

[0067] A stabilizer for electrochemical test paper. The stabilizer comprises components of gelatin, casein, chitobiose, BSA, astaxanthin, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl). A preparation method of the stabilizer comprises the following steps: dispersing the gelatin, casein, chitobiose, BSA, and astaxanthin in a TRIS-HCl buffer solution with a pH value of 2.5 to prepare a stabilizer 5# containing 5 wt% gelatin, 10 wt% casein, 5 wt% chitobiose, 0.5 wt% BSA, and 0.1 wt% astaxanthin.

[0068] Example 6

[0069] The invention discloses a stabilizer for electrochemical test paper. The stabilizer comprises components of gelatin, casein, chitobiose, BSA, astaxanthin, Tween-20, PEG-6000, and a TRIS-HCL buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCL). The preparation method of the stabilizer comprises the following steps: dispersing gelatin, casein, chitobiose, BSA, astaxanthin, Tween-20, and PEG-6000 in a TRIS-HCL buffer solution with a pH value of 2.5, and preparing a stabilizer 6# containing 5 wt% gelatin, 5 wt% casein, 1 wt% chitobiose, 0.5 wt% BSA, 0.1 wt% astaxanthin, 0.1 wt% Tween-20, and 0.1 wt% PEG-6000.

[0070] Example 7

[0071] An electrochemical test paper comprising lactate oxidase, potassium ferrocyanide, and stabilizer 1# of Example 1; a method for preparing the electrochemical test paper comprising:

[0072] (1) Preparation of electrodes:

[0073] ① Take the polyamide substrate;

[0074] ② Use silver ink to print part of the electrode on the polyamide substrate, and then bake it at 130℃ for 30 minutes to obtain a reference electrode;

[0075] ③ Print part of the electrode on the polyamide substrate using conductive carbon ink, and then bake it at 130℃ for 30 minutes to obtain the working electrode;

[0076] ④ Use insulating ink to print part of the electrode on the polyamide substrate, and then bake it at 130℃ for 30min to obtain the counter electrode.

[0077] (2) Lactate oxidase, potassium ferrocyanide and stabilizer 1# were mixed to prepare a mixed solution having a pH value of 2.5 and containing 0.1 wt% of lactate oxidase and 0.1 wt% of potassium ferrocyanide.

[0078] (3) The mixed solution obtained in step (2) is dispensed onto the conductive carbon ink coating of the electrode, and then the electrode is dried in a tunnel oven at 37° C. for 30 min to obtain electrochemical test paper 1#.

[0079] Example 8

[0080] An electrochemical test paper, which is different from Example 7 in that the electrochemical test paper contains stabilizer 2# of Example 2, to obtain electrochemical test paper 2#.

[0081] Example 9

[0082] An electrochemical test paper, which is different from Example 7 in that the electrochemical test paper contains stabilizer 3# of Example 3, to obtain electrochemical test paper 3#.

[0083] Example 10

[0084] An electrochemical test paper, which is different from Example 7 in that the electrochemical test paper contains stabilizer 4# of Example 4, to obtain electrochemical test paper 4#.

[0085] Example 11

[0086] An electrochemical test paper, which is different from Example 7 in that the electrochemical test paper contains stabilizer 5# of Example 5, to obtain electrochemical test paper 5#.

[0087] Example 12

[0088] An electrochemical test paper, which is different from Example 7 in that the electrochemical test paper contains stabilizer 6# of Example 6, to obtain electrochemical test paper 6#.

[0089] Example 13

[0090] An electrochemical test paper comprising urate oxidase, potassium ferrocyanide, and stabilizer 6# of Example 6; a method for preparing the electrochemical test paper comprising:

[0091] (1) Preparation of electrodes:

[0092] ① Take the polyamide substrate;

[0093] ② Use silver ink to print part of the electrode on the polyamide substrate, and then bake it at 130℃ for 30 minutes to obtain a reference electrode;

[0094] ③ Print part of the electrode on the polyamide substrate using conductive carbon ink, and then bake it at 130℃ for 30 minutes to obtain the working electrode;

[0095] ④ Use insulating ink to print part of the electrode on the polyamide substrate, and then bake it at 130℃ for 30min to obtain the counter electrode.

[0096] (2) Urate oxidase, potassium ferrocyanide and stabilizer 6# were mixed to prepare a mixed solution having a pH value of 2.5 and containing 0.1 wt% of urate oxidase and 0.1 wt% of potassium ferrocyanide.

[0097] (3) The mixed solution obtained in step (2) is dispensed onto the conductive carbon ink coating of the electrode, and then the electrode is dried in a tunnel oven at 37° C. for 30 min to obtain electrochemical test paper 7#.

[0098] 1. Product inspection

[0099] A. Inspection of electrochemical test paper 6#

[0100] (1) Stability investigation

[0101] Four whole blood samples containing lactate concentrations of 1.2 mol / L, 3.5 mol / L, 10.5 mol / L, and 18.5 mol / L, respectively (the actual lactate concentrations of the whole blood samples in Table 1 were determined using a lactate assay kit (lactate oxidase method) produced by MacBio Inc. on an automatic biochemical analyzer (Model C800)) were tested using electrochemical test paper #6 stored at room temperature. The electrochemical test paper #6 was then stored at 55°C and tested at room temperature after 7, 14, 21, and 28 days of storage. The measured data and deviations are shown in Table 1 below:

[0102] Table 1 Stability test results of electrochemical test paper 6#

[0103] (2) Repeatability and accuracy investigation

[0104] Ten whole blood samples containing specific lactate concentrations as shown in Table 2 below (the actual lactate concentrations of the whole blood samples in Table 2 were determined using a lactate assay kit (lactate oxidase method) manufactured by MacBio Inc. and tested on a fully automatic biochemical analyzer (Model C800)) were tested using electrochemical test paper #6 stored at room temperature. Each whole blood sample was tested 40 times.

[0105] 1) Repeatability study

[0106] For four whole blood samples with lactate concentrations of 0.65 mol / L, 1.75 mol / L, 2.90 mol / L, and 4.50 mol / L, the standard deviation of the data obtained by 40 tests was calculated; for six whole blood samples with lactate concentrations of 6.45 mol / L, 9.35 mol / L, 11.25 mol / L, 13.65 mol / L, 15.65 mol / L, and 16.50 mol / L, the relative standard deviation of the data obtained by 40 tests was calculated; these were used as evaluation data for the repeatability investigation of the 10 whole blood samples. The results are shown in Table 2 below.

[0107] 2) Accuracy inspection

[0108] For the 10 whole blood samples, the average value of the 40 test results for each whole blood sample was calculated, and then the error was calculated using the average value. Among them, for the four whole blood samples with lactate concentrations of 0.65 mol / L, 1.75 mol / L, 2.90 mol / L, and 4.50 mol / L, the absolute error was calculated using the average value. For the six whole blood samples with lactate concentrations of 6.45 mol / L, 9.35 mol / L, 11.25 mol / L, 13.65 mol / L, 15.65 mol / L, and 16.50 mol / L, the relative error was calculated using the average value. The results are shown in Table 2 below as evaluation data for the accuracy investigation of the 10 whole blood samples.

[0109] Table 2 Results of repeatability and accuracy of electrochemical test paper 6#

[0110] B. Inspection of electrochemical test paper 7#

[0111] (1) Stability investigation

[0112] Four whole blood samples containing uric acid concentrations of 302 μmol / L, 489 μmol / L, 703 μmol / L, and 873 μmol / L, respectively (the actual uric acid concentrations of the whole blood samples in Table 3 were obtained using a uric acid assay kit (uricase method) produced by MacBio Inc. on an automatic biochemical analyzer (Model C800)). Electrochemical test paper #7 stored at room temperature was used for testing. Electrochemical test paper #7 was then stored at 55°C. After 7, 14, 21, and 28 days of storage, the electrochemical test paper #7 was taken out and tested at room temperature. The measured data and deviations are shown in Table 3 below:

[0113] Table 3 Stability test results of electrochemical test paper 7#

[0114] (2) Repeatability and accuracy investigation

[0115] The eight whole blood samples containing specific uric acid concentrations shown in Table 4 below (the actual uric acid concentrations of the whole blood samples in Table 4 were obtained by testing using a uric acid assay kit (uricase method) produced by MacBio Inc. on a fully automatic biochemical analyzer (Model C800)) were tested using electrochemical test paper #7 stored at room temperature. Each whole blood sample was tested 40 times.

[0116] 1) Repeatability study

[0117] For two whole blood samples with uric acid concentrations of 268umol / L and 323umol / L, the standard deviation of the data obtained by 40 tests was calculated; for six whole blood samples with uric acid concentrations of 440umol / L, 545umol / L, 719umol / L, 985umol / L, 1103umol / L, and 1260umol / L, the relative standard deviation of the data obtained by 40 tests was calculated; these were used as evaluation data for the repeatability investigation of the eight whole blood samples, and the results are shown in Table 4 below.

[0118] 2) Accuracy inspection

[0119] For the eight whole blood samples, the average value of the 40 test results for each whole blood sample was calculated, and then the error was calculated using the average value. Among them, for the two whole blood samples with uric acid concentrations of 268umol / L and 323umol / L, the average value was used to calculate the absolute error. For the six whole blood samples with uric acid concentrations of 440umol / L, 545umol / L, 719umol / L, 985umol / L, 1103umol / L, and 1260umol / L, the average value was used to calculate the relative error. The results are shown in Table 4 below as evaluation data for the accuracy inspection of the eight whole blood samples.

[0120] Table 4 Results of the repeatability and accuracy test of electrochemical test paper 7#

[0121] 2. Technical solution review (using electrochemical test paper containing lactate oxidase and potassium ferrocyanide)

[0122] (1) Investigation of the mass concentration of stabilizer components

[0123] 1) When the stabilizer components only include gelatin and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 5 below:

[0124] Table 5 Stability test results of electrochemical test paper

[0125] In the table, "×" indicates that when the concentration of lactic acid in the whole blood sample to be tested is ≤1.6 mol / L, the detection deviation is >±0.3 mol / L; when the concentration of lactic acid in the whole blood sample to be tested is >1.6 mol / L, the detection deviation is >±10%; in this case, the accuracy requirement of the test is not met.

[0126] 2) When the stabilizer components only include casein and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 6 below:

[0127] Table 6 Stability test results of electrochemical test paper

[0128] In the table, "×" indicates that when the concentration of lactic acid in the whole blood sample to be tested is ≤1.6 mol / L, the detection deviation is >±0.3 mol / L; when the concentration of lactic acid in the whole blood sample to be tested is >1.6 mol / L, the detection deviation is >±10%; in this case, the accuracy requirement of the test is not met.

[0129] 3) When the stabilizer components only include gelatin, casein, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 7 below:

[0130] Table 7 Stability test results of electrochemical test paper

[0131] In the table, "×" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is greater than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is greater than ±10%. In this case, the test accuracy requirements are not met. "√" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is less than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is less than ±10%. In this case, the test accuracy requirements are met.

[0132] 4) When the stabilizer components only include gelatin, casein, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt % TRIS-HCl), and the mass concentration of casein is 5 wt %, the stability test results of the electrochemical test paper are shown in Table 8 below:

[0133] Table 8 Stability test results of electrochemical test paper

[0134] In the table, "×" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is greater than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is greater than ±10%. In this case, the test accuracy requirements are not met. "√" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is less than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is less than ±10%. In this case, the test accuracy requirements are met.

[0135] 5) When the stabilizer components only include gelatin, casein, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt % TRIS-HCl), and the gelatin concentration is 5 wt %, the stability test results of the electrochemical test paper are shown in Table 9 below:

[0136] Table 9 Stability test results of electrochemical test paper

[0137] In the table, "×" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is greater than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is greater than ±10%. In this case, the test accuracy requirements are not met. "√" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is less than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is less than ±10%. In this case, the test accuracy requirements are met.

[0138] 6) When the stabilizer components only include gelatin, casein, chitobiose, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt % TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 10 below:

[0139] Table 10 Stability test results of electrochemical test paper

[0140] In the table, "×" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is greater than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is greater than ±10%. In this case, the test accuracy requirements are not met. "√" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is less than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is less than ±10%. In this case, the test accuracy requirements are met.

[0141] 7) When the stabilizer components only include gelatin, casein, chitobiose, BSA, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt % TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 11 below:

[0142] Table 11 Stability test results of electrochemical test paper

[0143] In the table, "×" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is greater than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is greater than ±10%. In this case, the test accuracy requirements are not met. "√" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is less than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is less than ±10%. In this case, the test accuracy requirements are met.

[0144] 8) When the stabilizer components only include gelatin, casein, chitobiose, astaxanthin, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt % TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 12 below:

[0145] Table 12 Stability test results of electrochemical test paper

[0146] In the table, "×" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is greater than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is greater than ±10%. In this case, the test accuracy requirements are not met. "√" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is less than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is less than ±10%. In this case, the test accuracy requirements are met.

[0147] (2) Investigation of stabilizer components

[0148] 1) When the stabilizer components only include fructose, casein, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 13 below:

[0149] Table 13 Stability test results of electrochemical test paper (fructose instead of gelatin)

[0150] In the table, "×" indicates that when the concentration of lactic acid in the whole blood sample to be tested is ≤1.6 mol / L, the detection deviation is >±0.3 mol / L; when the concentration of lactic acid in the whole blood sample to be tested is >1.6 mol / L, the detection deviation is >±10%; in this case, the accuracy requirement of the test is not met.

[0151] 2) When the stabilizer components only include lactose, casein, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 14 below:

[0152] Table 14 Stability test results of electrochemical test paper (lactose replaces gelatin)

[0153] In the table, "×" indicates that when the concentration of lactic acid in the whole blood sample to be tested is ≤1.6 mol / L, the detection deviation is >±0.3 mol / L; when the concentration of lactic acid in the whole blood sample to be tested is >1.6 mol / L, the detection deviation is >±10%; in this case, the accuracy requirement of the test is not met.

[0154] 3) When the stabilizer components only include trehalose, casein, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 15 below:

[0155] Table 15 Stability test results of electrochemical test paper (trehalose instead of gelatin)

[0156] In the table, "×" indicates that when the concentration of lactic acid in the whole blood sample to be tested is ≤1.6 mol / L, the detection deviation is >±0.3 mol / L; when the concentration of lactic acid in the whole blood sample to be tested is >1.6 mol / L, the detection deviation is >±10%; in this case, the accuracy requirement of the test is not met.

[0157] 4) When the stabilizer components only include sucrose, casein, and a TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 16 below:

[0158] Table 16 Stability test results of electrochemical test paper (sucrose instead of gelatin)

[0159] In the table, "×" indicates that when the concentration of lactic acid in the whole blood sample to be tested is ≤1.6 mol / L, the detection deviation is >±0.3 mol / L; when the concentration of lactic acid in the whole blood sample to be tested is >1.6 mol / L, the detection deviation is >±10%; in this case, the accuracy requirement of the test is not met.

[0160] 5) When the stabilizer components only include gelatin, BSA, and TRIS-HCl buffer solution with a pH value of 2.5 (containing 0.1 wt% TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 17 below:

[0161] Table 17 Stability study results of electrochemical test paper (BSA replaces casein)

[0162] In the table, "×" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is greater than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is greater than ±10%. In this case, the test accuracy requirements are not met. "√" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is less than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is less than ±10%. In this case, the test accuracy requirements are met.

[0163] (3) pH value of stabilizer

[0164] When the stabilizer components only include 5wt% gelatin, 10wt% casein, and TRIS-HCl buffer solution (containing 0.1wt% TRIS-HCl), the stability test results of the electrochemical test paper are shown in Table 18 below:

[0165] Table 18 Stability test results of electrochemical test paper

[0166] In the table, "×" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is greater than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is greater than ±10%. In this case, the test accuracy requirements are not met. "√" indicates that when the lactate concentration in the whole blood sample is ≤1.6 mol / L, the detection deviation is less than ±0.3 mol / L; when the lactate concentration in the whole blood sample is greater than 1.6 mol / L, the detection deviation is less than ±10%. In this case, the test accuracy requirements are met.

[0167] The detection deviations used to evaluate the stability study results in Tables 5-18 above are all based on the lactate concentration of the whole blood sample obtained by testing on a fully automatic biochemical analyzer (Model C800) using the lactate determination kit (lactate oxidase method) produced by MacBio Inc. as the actual lactate concentration, and the value obtained by calculating the deviation between the result of the actual electrochemical test paper test mentioned in the present invention and the actual lactate concentration.

[0168] It should be noted that the embodiments described above are only used to explain the present invention and do not constitute any limitation of the present invention. The present invention has been described with reference to the embodiments, but it should be understood that the words used therein are descriptive and explanatory words, rather than restrictive words. The present invention may be modified as specified within the scope of the claims of the present invention, and the present invention may be revised without departing from the scope and spirit of the present invention. Although the present invention described therein relates to specific methods, materials and embodiments, it is not intended that the present invention is limited to the specific examples disclosed therein. On the contrary, the present invention can be extended to all other methods and applications with the same function.

Claims

1. A stabilizer for electrochemical test paper, It is characterized in that The components of the stabilizer include: colloid, casein, a buffer solution with a pH value of 2-5, and optional chitosan oligosaccharide, optional bovine serum albumin, and optional preservative; the mass percentage of the colloid in the stabilizer is 0.8-5wt%, the mass percentage of the casein is 0.2-10wt%, the mass percentage of the chitosan oligosaccharide is 0-5wt%, the mass percentage of the bovine serum albumin is 0-2wt%, and the mass percentage of the preservative is 0-0.1wt%.

2. The stabilizer according to claim 1, It is characterized in that The components of the stabilizer include: colloid, casein, and a buffer solution with a pH value of 2 to 5; the mass percentage of the colloid in the stabilizer is 2 to 5wt%, and the mass percentage of the casein is 5 to 10wt%, or the mass percentage of the colloid in the stabilizer is 3 to 5wt%, and the mass percentage of the casein is 4 to 10wt%, or the mass percentage of the colloid in the stabilizer is 5wt%, and the mass percentage of the casein is 0.2 to 10wt%.

3. The stabilizer according to claim 1, It is characterized in that The components of the stabilizer include: colloid, casein, chitosan oligosaccharide, and a buffer solution with a pH value of 2 to 5; the mass percentage of the colloid in the stabilizer is 2 to 5wt%, the mass percentage of the casein is 3 to 10wt%, and the mass percentage of the chitosan oligosaccharide is 2 to 5wt%; or The components of the stabilizer include: colloid, casein, chitosan oligosaccharide, preservative, and a buffer solution with a pH value of 2 to 5; the mass percentage of the colloid in the stabilizer is 2 to 5wt%, the mass percentage of the casein is 3 to 10wt%, the mass percentage of the chitosan oligosaccharide is 2 to 5wt%, and the mass percentage of the preservative is 0.1wt%; or, The components of the stabilizer include: colloid, casein, chitosan oligosaccharide, BSA, preservative, and a buffer solution with a pH value of 2-5; the mass percentage of the colloid in the stabilizer is 0.8-5wt%, the mass percentage of the casein is 1-10wt%, the mass percentage of the chitosan oligosaccharide is 0.8-5wt%, the mass percentage of the BSA is 0.5-2wt%, and the mass percentage of the preservative is 0-0.1wt%.

4. A stabilizer according to any one of claims 1 to 3, It is characterized in that The colloid is selected from any one or more of gelatin, pectin, carrageenan, and agar; preferably, the colloid is gelatin; and / or, The buffer solution is selected from any one or more of TRIS-HCL buffer solution, citric acid-disodium hydrogen phosphate, ammonia-ammonium chloride buffer, acetic acid-sodium acetate buffer, phosphate buffer, and citric acid; preferably, the buffer solution is selected from TRIS-HCL buffer solution; more preferably, the TRIS-HCL buffer solution The mass percentage of TRIS-HCL is 0 to 0.2 wt%, preferably 0.1 wt%; and / or, The chitosan oligosaccharide has a polymerization degree of 2 to 10; preferably, the chitosan oligosaccharide has a polymerization degree of 2 to 6; more preferably, the chitosan oligosaccharide is selected from chitobiose and / or chitotriose; and / or, The preservative is selected from astaxanthin.

5. A stabilizer according to any one of claims 1 to 4, It is characterized in that The stabilizer component also includes polyethylene glycol; preferably, the molecular weight of the polyethylene glycol is 4000-6000; more preferably, the mass percentage of the polyethylene glycol in the stabilizer is 0-0.2wt%, preferably 0.1wt%; and / or, The components of the stabilizer also include a surfactant; preferably, the surfactant is a nonionic surfactant; more preferably, the surfactant is selected from Tween-20 and Tween-80; further preferably, the mass percentage of the surfactant in the stabilizer is 0-0.2wt%, preferably 0.1wt%.

6. Use of the stabilizer described in any one of claims 1 to 5 in the preparation of electrochemical test paper; preferably, the electrochemical test paper is an electrochemical test paper containing biological enzymes and potassium ferrocyanide components; more preferably, the biological enzyme is selected from at least one of lactate oxidase, urate oxidase, cholesterol oxidase, phosphate oxidase, bilirubin oxidase, phosphate oxidase, galactose oxidase, pyruvate oxidase, D-amino acid oxidase, L-amino acid oxidase, choline oxidase, xanthine oxidase, sarcosine oxidase, fructose dehydrogenase, and amino acid dehydrogenase.

7. An electrochemical test paper, comprising a biological enzyme layer, wherein the biological enzyme layer comprises a biological enzyme, potassium ferrocyanide and a stabilizer according to any one of claims 1 to 5; preferably, the biological enzyme is selected from at least one of lactate oxidase, urate oxidase, cholesterol oxidase, phosphate oxidase, bilirubin oxidase, phosphate oxidase, galactose oxidase, pyruvate oxidase, D-amino acid oxidase, L-amino acid oxidase, choline oxidase, xanthine oxidase, sarcosine oxidase, fructose dehydrogenase and amino acid dehydrogenase.

8. The electrochemical test paper according to claim 7, It is characterized in that The biological enzyme layer is prepared by mixing biological enzyme, potassium ferrocyanide and the stabilizer according to any one of claims 1 to 5 into a mixed solution and then drying; preferably, the pH value of the mixed solution is 2-5, the content of biological enzyme in the mixed solution is 0.05-5wt%, and the content of potassium ferrocyanide is 0.05-7.5wt%; more preferably, the content of biological enzyme in the mixed solution is 0.1-3wt%, and the content of potassium ferrocyanide is 0.1-5wt%.

9. The method for preparing the electrochemical test paper according to claim 7 or 8, wherein the method include: (1) preparing electrodes; (2) mixing the biological enzyme, potassium ferrocyanide and the stabilizer according to any one of claims 1 to 5 to prepare a mixed solution having a pH value of 2 to 5 and containing 0.05 to 5 wt % of the biological enzyme and 0.05 to 7.5 wt % of potassium ferrocyanide; (3) applying the mixed solution obtained in step (2) on the conductive carbon ink coating of the electrode and drying the mixture; Preferably, the electrode prepared in step (1) consists of a substrate and a reference electrode, a counter electrode and a working electrode arranged in parallel on the substrate; More preferably, the substrate is made of a polymer insulating material, preferably polyamide; and / or, The reference electrode is a portion of the electrode printed with a silver ink coating; and / or, The counter electrode is a partial electrode printed with an insulating ink coating; and / or, The working electrode is a portion of the electrode printed with a conductive carbon ink coating.

10. An enzyme sensor comprising the electrochemical test paper according to claim 7 or 8 or the electrochemical test paper prepared by the preparation method according to claim 9.

Citation Information

Patent Citations

  • Enzyme detection reagent of uric acid for electrochemical test strip

    CN103175871A

  • Gastrin-releasing peptide precursor diluent, and application and kit thereof

    CN108333360A

  • Reagent and electrochemical sensor

    CN109085218A

  • Test strip for detecting creatinine by electrochemical method and preparation method thereof

    CN111189899A

  • Anti-interference electrochemical uric acid test paper and preparation method thereof

    CN114235925A